• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Healthnostics and GMD Addressing the Expanding $92 Billion Diabetic Supply Market

Posted on: Thursday, 12 June 2008, 09:01 CDT

Healthnostics, Inc. (Pink Sheets: HNSO), a medical and biotechnology information and technology company, is leveraging their relationship with GMD Inc. ("GMD") to expand GMD's leading position in the growing diabetes supply market. Healthnostics and GMD believe that because the diabetic supply market is portioned into mostly small and medium-sized companies the opportunities for GMD's growth and consolidation opportunities abound.

GMD is currently positioned to take full advantage of the growing demand for accessible and well priced diabetic products and supplies, and expects with such an expanding market to increase revenues in the next fiscal year beginning July 1, 2008.

Currently there are $92 Billion in direct health costs associated with diabetes. 54 million Americans are pre-diabetic, with nearly 15 million diagnosed with diabetes and 1.5 million more diagnosed each year, according to the Centers for Disease Control (CDC). This epidemic increases the overall risk for death among people with diabetes to about 2 times that of people without diabetes. GMD is supplying the products and drugs required for these millions of diabetic patients to maintain control of this life-threatening disease.

"Healthnostics' and GMDs' management teams have the vision and experience to build a leading diabetic supply organization. Healthnostics brings the healthcare insight and development resources to GMD that can only help capitalize on the great start GMD has made in penetrating this growing market," said Alan Grofe, President of Healthnostics and CEO of GMD.

About GMD, Inc.

Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetes maintenance medications, diabetic shoes and orthopedic inserts.

For further information, please visit Global Medical Direct www.globalmeddirect.com.

For further information concerning Healthnostics, please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, MedNets www.mednets.com, and FamilyMedicalNet www.familymedicalnet.com.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Source: Business Wire

More News in this Category